COMPUGEN LTD./ IL0010852080 /
2024-04-24 8:06:55 AM | Chg. +0.076 | Volume | Bid10:06:35 AM | Ask10:06:35 AM | High | Low |
---|---|---|---|---|---|---|
1.816EUR | +4.37% | 0 Turnover: 0.000 |
1.816Bid Size: 1,379 | 1.888Ask Size: 1,323 | 1.816 | 1.816 |
GlobeNewswire
2022-03-08
XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events
GlobeNewswire
2021-11-04
XOMA Reports Third Quarter 2021 Financial Results and Highlights Recent Operational Events
GlobeNewswire
2021-05-06
XOMA Reports First Quarter 2021 Financial Results and Highlights Recent Operational Events
GlobeNewswire
2021-03-11
Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D.
GlobeNewswire
2021-01-20
Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors
GlobeNewswire
2020-05-05
XOMA Reports First Quarter 2020 Financial Results and Provides COVID-19 Business Update
GlobeNewswire
2020-03-10
XOMA Reports Fourth Quarter and Full-Year 2019 Financial Results and Operating Highlights
GlobeNewswire
2019-12-12
Janpix, Inc. Announces Appointment of Sanford (Sandy) Zweifach as Executive Chairman to its Board of...
GlobeNewswire
2019-10-22
Global Predisposition Biomarkers Market by Application, End-user & Region - Forecast to 2024
GlobeNewswire
2019-04-12
Report: Exploring Fundamental Drivers Behind Masco, Ascena Retail Group, Minerva Neurosciences, Comp...
GlobeNewswire
2019-01-30
Kamada Appoints Senior Biopharmaceutical Executive Michal Ayalon, Ph.D., as Vice President of Resear...
GlobeNewswire
2018-12-17
Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...
GlobeNewswire
2018-05-03
Outsourcing in Drug Discovery 2017-2018 & 2022 - Focus on the Contract Research Organization (CRO) M...
GlobeNewswire
2017-11-16
Antibody Drug Conjugates Market, 2030 - Market is Anticipated to Grow at a CAGR to 19.4%
GlobeNewswire
2007-06-14
DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Co...
GlobeNewswire
2007-04-17
DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Si...
GlobeNewswire
2003-11-17
LORANTIS RECEIVES £25 ($42) MILLION IN NEW FINANCING LED BY APAX
PARTNERS FUNDS